[English] 日本語

- EMDB-47333: CryoEM structure of the human antibodies PIV3HN-05 and PIV3HN-13 ... -
+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | CryoEM structure of the human antibodies PIV3HN-05 and PIV3HN-13 in complex with the parainfluenza virus hemagglutinin-neuraminidase protein | |||||||||
![]() | Unsharpened map from nonuniform refinement | |||||||||
![]() |
| |||||||||
![]() | Hemagglutinin-neuraminidase / human monoclonal antibody / VIRAL PROTEIN / VIRAL PROTEIN-IMMUNE SYSTEM complex | |||||||||
Function / homology | ![]() exo-alpha-sialidase activity / host cell surface receptor binding / symbiont entry into host cell / viral envelope / virion attachment to host cell / host cell plasma membrane / virion membrane / membrane Similarity search - Function | |||||||||
Biological species | ![]() ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.57 Å | |||||||||
![]() | Mousa JJ / Miller RJ | |||||||||
Funding support | ![]()
| |||||||||
![]() | ![]() Title: The structural basis of protective and nonprotective human monoclonal antibodies targeting the parainfluenza virus type 3 hemagglutinin-neuraminidase. Authors: Rose J Miller / Ian A Durie / Aaron D Gingerich / Mohamed A Elbehairy / Abigail G Branch / Riley G Davis / Nada Abbadi / Melinda A Brindley / Jarrod J Mousa / ![]() ![]() Abstract: Parainfluenza virus 3 (PIV3) infection poses a substantial risk to vulnerable groups including infants, the elderly, and immunocompromised individuals, and lacks effective treatments or vaccines. ...Parainfluenza virus 3 (PIV3) infection poses a substantial risk to vulnerable groups including infants, the elderly, and immunocompromised individuals, and lacks effective treatments or vaccines. This study focuses on targeting the hemagglutinin-neuraminidase (HN) protein, a structural glycoprotein of PIV3 critical for viral infection and egress. With the objective of targeting these activities of HN, we identified eight neutralizing human monoclonal antibodies (mAbs) with potent effects on viral neutralization, cell-cell fusion inhibition, and complement deposition. Three epitopes on PIV3 HN were delineated and one epitope, Site 2, elicits a mAb with cross-neutralizing ability against PIV1 and PIV3. Cryo-EM revealed the cross-neutralizing mAb utilizes a long CDR3 loop to bind inside the pocket of the sialic acid binding site. Additionally, we resolved the structure of a non-protective mAb binding to Site 1 near the HN:F-interaction site. The potent Site 2-directed mAb demonstrated clinical efficacy in hamsters, reducing viral replication prophylactically and therapeutically. These findings advance our understanding of PIV3 immunity and underscore the significance of targeting HN for clinical therapeutic development against PIV3. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 215.1 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 21.3 KB 21.3 KB | Display Display | ![]() |
FSC (resolution estimation) | ![]() | 13.2 KB | Display | ![]() |
Images | ![]() | 53.2 KB | ||
Filedesc metadata | ![]() | 6.4 KB | ||
Others | ![]() ![]() ![]() | 122.4 MB 226.6 MB 226.6 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 9dzqMC ![]() 9b2wC M: atomic model generated by this map C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
EMDB pages | ![]() ![]() |
---|---|
Related items in Molecule of the Month |
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Unsharpened map from nonuniform refinement | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 1.03 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Additional map: #1
File | emd_47333_additional_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: Unsharpened map from nonuniform refinement
File | emd_47333_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Unsharpened map from nonuniform refinement | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: Unsharpened map from nonuniform refinement
File | emd_47333_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Unsharpened map from nonuniform refinement | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : Complex of the PIV3 HN protein with two human antibodies
Entire | Name: Complex of the PIV3 HN protein with two human antibodies |
---|---|
Components |
|
-Supramolecule #1: Complex of the PIV3 HN protein with two human antibodies
Supramolecule | Name: Complex of the PIV3 HN protein with two human antibodies type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 200 KDa |
-Macromolecule #1: Hemagglutinin-neuraminidase
Macromolecule | Name: Hemagglutinin-neuraminidase / type: protein_or_peptide / ID: 1 / Number of copies: 2 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 51.625516 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: HHHHHHSLVP RGSISEITIR NDNQEVLPQR ITHDVGIKPL NPDDFWRCTS GLPSLMKTPK IRLMPGPGLL AMPTTVDGCV RTPSLVIND LIYAYTSNLI TRGCQDIGKS YQVLQIGIIT VNSDLVPDLN PRISHTFNIN DNRKSCSLAL LNTDVYQLCS T PKVDERSD ...String: HHHHHHSLVP RGSISEITIR NDNQEVLPQR ITHDVGIKPL NPDDFWRCTS GLPSLMKTPK IRLMPGPGLL AMPTTVDGCV RTPSLVIND LIYAYTSNLI TRGCQDIGKS YQVLQIGIIT VNSDLVPDLN PRISHTFNIN DNRKSCSLAL LNTDVYQLCS T PKVDERSD YASSGIEDIV LDIVNYDGSI STTRFKNNNI SFDQPYAALY PSVGPGIYYK GKIIFLGYGG LEHPINENVI CN TTGCPGK TQRDCNQASH SPWFSDRRMV NSIIVADKGL NSIPKLKVWT ISMRQNYWGS EGRLLLLGNK IYIYTRSTSW HSK LQLGII DITDYSDIRI KWTWHNVLSR PGNNECPWGH SCPDGCITGV YTDAYPLNPT GSIVSSVILD SQKSRVNPVI TYST ATERV NELAILNRTL SAGYTTTSCI THYNKGYCFH IVEINHKSLN TFQPMLFKTE IPKSCS UniProtKB: Hemagglutinin-neuraminidase |
-Macromolecule #2: Human antibody PIV3HN-05 heavy chain
Macromolecule | Name: Human antibody PIV3HN-05 heavy chain / type: protein_or_peptide / ID: 2 / Number of copies: 2 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 24.696654 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: EVQLVESGGG VVQPGGSLRL SCVASGLSLS PNWMHWVRQA PGKGLVWVSR ISDNGDTTNY AGSVMGRFTI SRDNAKNTLY LQMNNLRAD DTAVYFCVRE SAVISSPSWG LYDTAYHFDP WGQGTLVTVS SASTKGPSVF PLAPSSKSTS GGTAALGCLV K DYFPEPVT ...String: EVQLVESGGG VVQPGGSLRL SCVASGLSLS PNWMHWVRQA PGKGLVWVSR ISDNGDTTNY AGSVMGRFTI SRDNAKNTLY LQMNNLRAD DTAVYFCVRE SAVISSPSWG LYDTAYHFDP WGQGTLVTVS SASTKGPSVF PLAPSSKSTS GGTAALGCLV K DYFPEPVT VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKRV EPKSC |
-Macromolecule #3: Human antibody PIV3HN-05 light chain
Macromolecule | Name: Human antibody PIV3HN-05 light chain / type: protein_or_peptide / ID: 3 / Number of copies: 2 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 22.87715 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: QSVLTQPPSA SGTPGQGVTI SCSGSNSNIG TNAVDWYQQF PGTAPRLLIF NDNQRPSGVP DRFSGSRSGT SASLAISGLQ SEDEAVYYC ATWDDSLNGP VVFGGGTKLT VLRQPKAAPS VTLFPPSSEE LQANKATLVC LISDFYPGAV TVAWKADSSP V KAGVETTT ...String: QSVLTQPPSA SGTPGQGVTI SCSGSNSNIG TNAVDWYQQF PGTAPRLLIF NDNQRPSGVP DRFSGSRSGT SASLAISGLQ SEDEAVYYC ATWDDSLNGP VVFGGGTKLT VLRQPKAAPS VTLFPPSSEE LQANKATLVC LISDFYPGAV TVAWKADSSP V KAGVETTT PSKQSNNKYA ASSYLSLTPE QWKSHRSYSC QVTHEGSTVE KTVAPTECS |
-Macromolecule #4: Human antibody PIV3HN-13 heavy chain
Macromolecule | Name: Human antibody PIV3HN-13 heavy chain / type: protein_or_peptide / ID: 4 / Number of copies: 2 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 23.686352 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: EVQLLESGGA LVQPGGSLRV SCAASGFSFS SYAMSWLRQT PGKGLEWVSA IGGSGHSTYY ADSVQGRFTV SRDNSKDTLY LQMNSLRAE DTAVYYCAKF FRSDGVFHFD YWGPGNPGSP SPASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT V SWNSGALT ...String: EVQLLESGGA LVQPGGSLRV SCAASGFSFS SYAMSWLRQT PGKGLEWVSA IGGSGHSTYY ADSVQGRFTV SRDNSKDTLY LQMNSLRAE DTAVYYCAKF FRSDGVFHFD YWGPGNPGSP SPASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT V SWNSGALT SGVHTFPAVL QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKR VEPKSC |
-Macromolecule #5: Human antibody PIV3HN-13 light chain
Macromolecule | Name: Human antibody PIV3HN-13 light chain / type: protein_or_peptide / ID: 5 / Number of copies: 2 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 23.785422 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: DIVMTQSPLS LPVTPGEPAS ISCRSSQSLR HSDGNNYLDW YLQKPGQSPQ LLIYLGSNRA SGVPDRFSGS GSGSDFTLKI SRVEAEDVG VYYCMQALQT PTFGQGTKVE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ S GNSQESVT ...String: DIVMTQSPLS LPVTPGEPAS ISCRSSQSLR HSDGNNYLDW YLQKPGQSPQ LLIYLGSNRA SGVPDRFSGS GSGSDFTLKI SRVEAEDVG VYYCMQALQT PTFGQGTKVE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ S GNSQESVT EQDSKDSTYS LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 1 mg/mL |
---|---|
Buffer | pH: 7.5 / Details: 20 mM Tris, pH 7.5 120 mM NaCl |
Vitrification | Cryogen name: ETHANE / Instrument: FEI VITROBOT MARK IV |
Details | Monodisperse |
-
Electron microscopy
Microscope | TFS KRIOS |
---|---|
Image recording | Film or detector model: GATAN K2 IS (4k x 4k) / Average electron dose: 52.8 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.6 µm / Nominal defocus min: 0.8 µm |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
Refinement | Protocol: RIGID BODY FIT |
---|---|
Output model | ![]() PDB-9dzq: |